4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-23-011080
CEO, CFO, Director gave up 435 shares (to pay taxes)
- CEO, CFO, Director acquired 1,309 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Finley John David · CEO, CFO, Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 1 in the form | +1,309 | 4,283 | D | ||
| 2023-04-03 | Shares withheld for taxes : show line 2 in the form | −435 | $2.01 | $874 | 3,848 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-03 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,309 | 3,927 | D |
Loading xslF345X04/ownership.xml…